Top Markets
Coin of the day
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
शेयरों में रैंक #29654
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
शेयर मूल्य
$0.68377137
अंतिम समन्वयन: 2023-05-23
मार्केट कैप
$20.23M
बदलाव (1 दिन)
-0.60%
बदलाव (1 वर्ष)
0.00%
देश
SE
व्यापार Medivir AB (publ) (MVIR-B)

श्रेणी

Medivir AB (publ) (MVIR-B) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.72 (2023-05-01 को)

दिन का सबसे निम्न समापन मूल्य: $13.34 (2000-01-01 को)
Medivir AB (publ) के स्टॉक मूल्य का इतिहास 2000 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2023 -20.72%
2022 -17.55%
2021 16.81%
2020 -44.31%
2019 -43.10%
2018 -50.21%
2017 -38.87%
2016 22.76%
2015 -42.23%
2014 2.07%
2013 41.17%
2012 4.01%
2011 -52.79%
2010 87.56%
2009 95.64%
2008 -29.03%
2007 38.44%
2006 11.49%
2005 -57.32%
2004 13.36%
2003 186.51%
2002 -4.10%
2001 -61.41%
2000 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$740.28 6.71%
CH
$1.07K -5.58%
KR